Skip to main content

Table 2 Anti-TB drugs and their dosage used in the trial

From: Efficacy of ultra-short course chemotherapy for new smear positive drug susceptible pulmonary tuberculosis: study protocol of a multicenter randomized controlled clinical trial

Drugs (Abbreviation) Formulation Dosage Daily
<50 kg ≥ 50 kg
Isoniazid (H) 100 mg/tablet 300 mg 300 mg
Rifampicin (R) 150 mg/ tablet 450 mg 600 mg
Ethambutol (E) 250 mg/ tablet 750 mg 1000 mg
Pyrazinamid (Z) 250 mg/ tablet 1500 mg 30 mg/kg
Levofloxacin (Lfx) 100 mg/ tablet 600 mg 800 mg